CHIKV Mutant

Chikungunya Mutant (A226V) E1 Recombinant
Shipped with Ice Packs
In Stock

Description

Definition and Significance of CHIKV Mutants

CHIKV mutants arise from nucleotide substitutions, insertions, or deletions in the viral genome, which encodes nonstructural (nsP1–4) and structural proteins (capsid, E1, E2, E3). These mutations are critical for understanding viral evolution, pathogenesis, and therapeutic targeting .

E1-A226V Mutation

  • Location: Envelope glycoprotein E1 (residue 226).

  • Effect:

    • Enhances CHIKV infectivity in Aedes albopictus mosquitoes by 10- to 100-fold .

    • Reduces cholesterol dependence, facilitating viral entry into mosquito midgut cells .

    • Associated with large-scale epidemics (e.g., 2005–2006 Réunion outbreak) .

nsP1 Mutations

  • Examples: S454G, W456R, G230R, V326M.

  • Effect:

    • Confer resistance to capping inhibitors (e.g., CHVB-032, MADTP-314) by altering methyltransferase/guanylyltransferase activity .

    • Reduce viral RNA replication efficiency by 50–80% in mammalian cells .

nsP2 Mutations

  • Examples: C478A (protease inactivation), M703T, S482A.

  • Effect:

    • Disrupt polyprotein processing (P1234→nsP1–4), reducing replication complex formation .

    • Attenuate viral pathogenesis in vivo, making them candidates for live-attenuated vaccines .

nsP4 Mutations

  • Examples: P187S, K291R.

  • Effect:

    • Confer resistance to nucleoside analogs (e.g., favipiravir, ribavirin) .

    • Reduce RNA-dependent RNA polymerase activity by 40–60% .

Replication Efficiency

MutationReplication Efficiency (vs. Wild Type)Host Cell TypeSource
E1-A226VUnchangedMammalian/Mosquito
nsP1-S454G18-fold reductionVero cells
nsP2-C478A90% reductionBHK-21 cells

Vector Specificity

  • E1-A226V increases midgut infectivity in Ae. albopictus by lowering the oral infectious dose 50 (OID50) from 6.5 to 4.7 log10 TCID50/mL .

  • Mutations in E2 (e.g., N219P) reduce viral dissemination to salivary glands by 70% .

Inhibitor Resistance

CompoundTargetResistance Mutation(s)Fold ResistanceSource
CHVB-032nsP1S454G + W456R>18
FavipiravirnsP4K291R5
Mycophenolic acidnsP1S23N + V302M8

Vaccine Candidates

  • R532H (nsP1): Reduces viremia by 99% in mouse models while eliciting neutralizing antibodies .

  • P718G (nsP2): Noncytotoxic replicon with retained immunogenicity .

Evolutionary and Epidemiological Relevance

  • E1-A226V facilitated CHIKV’s spread to regions dominated by Ae. albopictus, including Europe and the Americas .

  • nsP1/nsP2 mutations are under positive selection in response to host immune pressures .

Product Specs

Introduction

Chikungunya is a viral infection transmitted to humans through the bites of infected Aedes mosquitoes, primarily Aedes albopictus and Aedes aegypti. The virus can also infect animals, including monkeys, birds, cattle, and rodents. Symptoms typically appear 2-4 days after infection and include a sudden onset of fever, often accompanied by joint pain. The fever usually lasts for 2-7 days, while joint pain can persist for weeks, months, or even years. The mortality rate is less than 1 in 1,000. Outbreaks of chikungunya have been reported in Asia, Europe, and the Americas since 2004.

The chikungunya virus (CHIKV) has a single-stranded, positive-sense RNA genome containing approximately 11,800 nucleotides. This genome encodes two open reading frames. The virus's nucleocapsid, which houses the RNA genome, is enclosed within a protective lipid bilayer called the envelope. Embedded within the envelope are approximately 80 glycoprotein spikes, which are anchored to the viral envelope at their C-termini.

The virus produces a structural polyprotein from a subgenomic mRNA. This polyprotein contains the five structural proteins: capsid (C), E3, E2, 6K, and E1. The capsid protein is cleaved from the polyprotein and encapsidates the viral RNA. The remaining envelope polyprotein precursor (E3-E2-6K-E1) is transported to the endoplasmic reticulum, where host enzymes process it into the individual E3, E2, and E1 proteins. These proteins assemble into hetero-trimeric spikes on the virus's surface. The E1 and E2 proteins within these spikes play crucial roles in recognizing host cell receptors, mediating cell entry via pH-dependent endocytosis, and facilitating viral budding.

Description
Recombinant Chikungunya Mutant (A226V) E1 protein, produced in insect cells, is a modified version of the chikungunya virus E1 protein. It encompasses amino acids 1 to 415, with a specific mutation where the Alanine at position 226 in the wild-type CHIKV E1 gene is replaced with Valine. This mutation distinguishes it from the naturally occurring E1 protein. The protein has a molecular weight of approximately 50kDa. It constitutes the C-terminal portion of the E2-6K-E1 protein region. Purification of the CHIKV Mutant protein is achieved using a proprietary chromatographic technique, ensuring its isolation and separation from other cellular components.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
The CHIKV Mutant protein is supplied in a solution containing 1x Dulbecco's Phosphate-Buffered Saline (D-PBS) at pH 7.4, 0.1% Thimerosal (a preservative), 5mM EDTA (a chelating agent), and a protease inhibitor cocktail consisting of Leupeptin, Aprotinin, and Pepstatin A, each at a concentration of 1 µg/ml.
Stability
For short-term storage (2-4 weeks), the protein solution should be kept at 4°C. For extended storage, it is recommended to freeze the solution at -20°C. To prevent protein degradation during long-term storage, adding a carrier protein such as 0.1% HSA (human serum albumin) or BSA (bovine serum albumin) is advisable. Repeated freezing and thawing of the protein solution should be avoided to maintain protein stability.
Purity
The purity of the CHIKV Mutant protein is greater than 95%, as determined by SDS-PAGE analysis using a 12.5% polyacrylamide gel.
Source
Insect cells.
Amino Acid Sequence
YEHVTVIPNTVGVPYKTLVNRPGYSPMVLEMELLSVTLEPTLSLDYITCEYKTVIPSPYVKCC
GTAECKDKNLPDYSCKVFTGVYPFMWGGAYCFCDAENTQLSEAHVEKSESCKTEFASAYRAHT
ASASAKLRVLYQGNNITVTAYANGDHAVTVKDAKFIVGPMSSAWTPFDNKIVVYKGDVYNMDYP
PFGAGRPGQFGDIQSRTPESKDVYANTQLVLQRPAVGTVHVPYSQAPSGFKYWLKERGASLQHT
APFGCQIATNPVRAVNCAVGNMPISIDIPEAAFTRVVDAPSLTDMSCEVPACTHSSDFGGVAII
KYAASKKGKCAVHSMTNAVTIREAEIEVEGNSQLQISFSTALASAEFRVQVCSTQVHCAAECHP
PKDHIVNYPASHTTLGQDISATAMSWVQKITGG.

Q&A

What are CHIKV fidelity variants and how do they influence viral population diversity?

CHIKV fidelity variants are viral strains with mutations that affect the accuracy of genome replication. These variants are categorized as either high-fidelity (HiFi) or low-fidelity (LoFi) based on their mutation rates compared to wild-type virus. High-fidelity variants produce populations with lower genetic diversity, while low-fidelity variants generate more diverse viral populations during replication.

Specifically identified CHIKV fidelity variants include:

  • High-fidelity (HiFi): Contains the nsP4 C483Y mutation

  • Double-mutant high fidelity (DM HiFi): Contains both nsP2 G641D and nsP4 C483Y mutations

  • Low-fidelity (LoFi): Contains the nsP4 C483G mutation

These variants allow researchers to manipulate intrahost viral diversity experimentally, making them valuable tools for investigating how population diversity affects viral fitness, pathogenesis, and host immune responses.

How does CHIKV population diversity correlate with disease severity?

Research indicates that CHIKV populations with greater genetic diversity can cause more severe arthritic disease in mouse models. Studies using fidelity variants have demonstrated that genetically diverse CHIKV populations not only lead to more severe disease manifestations but also stimulate different antibody responses. Specifically, antibody responses against high-diversity populations showed reduced neutralization efficacy against low-diversity virus populations in vitro .

This correlation between viral diversity and disease severity highlights the importance of understanding viral population dynamics in the context of CHIKV pathogenesis. The ability of more diverse populations to potentially evade host immune responses may contribute to enhanced virulence and persistence of symptoms.

What sequencing approaches are most appropriate for studying CHIKV genetic diversity?

For comprehensive analysis of CHIKV genetic diversity, next-generation sequencing (NGS) approaches are significantly more effective than traditional Sanger sequencing methods. While earlier studies of CHIKV fidelity variants relied on Sanger sequencing of portions of the CHIKV genome (particularly parts of the E1 gene), this provides lower breadth and depth of coverage compared to NGS approaches .

When investigating population diversity:

  • Bacterial cloning with Sanger sequencing can provide a preliminary assessment of mutation frequencies but has limited sampling depth

  • NGS provides genome-wide coverage at high depth, revealing the complete spectrum of variants within a population

  • Direct measurement of mutation rates through specialized assays provides more accurate assessment of fidelity phenotypes than inferring fidelity indirectly from population diversity

Researchers should note that discrepancies between different measurement techniques have been observed, highlighting the importance of direct mutation rate measurements to clarify true fidelity phenotypes.

How can deep mutational scanning be applied to study CHIKV structural proteins?

Deep mutational scanning (DMS) offers a powerful high-throughput approach for simultaneously testing thousands of CHIKV protein variants against specific selective pressures. For CHIKV structural proteins, this technique has been successfully applied to p62 glycoprotein, which processes into E2 and E3 proteins involved in viral entry and egress.

The methodology involves:

  • Generating a plasmid library (mutDNA) containing numerous mutations throughout the target protein sequence

  • Transfecting cells with the plasmid library to produce a diverse virus library

  • Passaging the virus population to select for functional variants

  • Sequencing the resulting virus population to identify mutations that persist or are depleted

This approach has proven particularly valuable for mapping antibody epitopes, with researchers successfully using DMS libraries to confirm previously identified binding sites for well-characterized monoclonal antibodies like CHK-152 and CHK-265, as well as identifying targeting sites for antibodies with previously undefined specificities such as CHK-11 .

How do selective pressures differ for CHIKV mutants between mammalian and mosquito hosts?

CHIKV exhibits host-specific adaptation, particularly evident in the 3'UTR region of its genome. Research demonstrates opposite selective pressures operating in mammalian versus mosquito hosts, resulting in different viral population compositions.

Key observations include:

  • In mammalian cells, CHIKV variants with 3'UTR deletions (particularly of direct repeat sequences) emerge and predominate during passage

  • When these mammalian-adapted populations are introduced to mosquitoes, variants with longer 3'UTRs become dominant

  • In mosquitoes experimentally infected with CHIKV populations having impaired transmission rates, addition of direct repeat blocks through recombination leads to emergence of new variants with restored fitness

The 3'UTR of CHIKV appears to have a host-adaptable architecture where cycles of loss and gain of direct repeat (DR) copies occur during host switching. This adaptation is mediated through RNA recombination, which allows the virus to customize its 3'UTR to be optimally functional in each host environment .

What molecular mechanisms drive RNA recombination in CHIKV's 3'UTR?

RNA recombination in CHIKV's 3'UTR involves specific molecular features that facilitate template switching during RNA replication. Several key elements appear to guide this process:

  • AU-rich regions: Breakpoints cluster near sequences with high adenine and uracil content. The weaker RNA-RNA interactions formed by A/U base pairs likely favor RNA-dependent RNA polymerase (RdRp) dissociation from the template

  • Stem-loop structures: RNA structural elements, particularly stem-loops, may promote recombination by inhibiting the movement of RdRp along the template

  • Temperature effects: Although RNA structures appear slightly more stable at mosquito temperature compared to mammalian temperature, host-specific selective pressures rather than differences in recombination frequency likely drive the distinct spectrum of viral populations observed in insect versus mammalian cells

The organization of direct repeats in the 3'UTR significantly influences the variant spectrum in viral populations. Different CHIKV epidemic lineages show substantial variation in their 3'UTR organization, suggesting that these differences may impact their evolutionary potential and adaptation capabilities .

How can CHIKV fidelity variants be utilized to study host immune responses?

CHIKV fidelity variants provide valuable tools for investigating the relationship between viral population diversity and host immune responses. Research with these variants has revealed important insights into how viral diversity shapes antibody development and effectiveness.

Key applications include:

  • Comparing neutralizing antibody responses against high-diversity versus low-diversity viral populations

  • Investigating how population diversity affects the spectrum of epitopes presented to the immune system

  • Examining whether fidelity variants with reduced diversity might serve as better vaccine candidates

Studies have demonstrated that CHIKV populations with greater genetic diversity stimulate antibody responses with reduced cross-neutralization capacity against low-diversity virus populations, suggesting that viral diversity influences not only the magnitude but also the specificity of antibody responses .

What methodological approaches can resolve discordant fidelity phenotypes observed in different experimental systems?

Discordant phenotypes in CHIKV fidelity variant research highlight the complexity of accurately characterizing replication fidelity. To resolve these inconsistencies, researchers should employ multiple complementary approaches:

  • Direct measurement of mutation rates through biochemical assays with purified viral polymerase rather than inferring fidelity solely from population diversity measures

  • Comprehensive sequencing approaches:

    • Next-generation sequencing of the complete viral genome rather than targeted sequencing of specific regions

    • Analysis of multiple biological replicates to account for experimental variation

    • Statistical validation methods such as Grubbs' outlier tests to identify potentially anomalous results

  • Multi-host validation by testing fidelity phenotypes across relevant cell types:

    • Mammalian cells (e.g., BHK-21)

    • Mosquito cells (e.g., C6/36)

    • In vivo systems (e.g., mouse models, mosquito infections)

These approaches help distinguish true fidelity effects from adaptations that may arise in response to specific selective pressures in different experimental systems.

How can deep mutationally scanned (DMS) CHIKV libraries advance antibody epitope mapping?

Deep mutationally scanned (DMS) CHIKV libraries offer a comprehensive approach to antibody epitope mapping by simultaneously testing thousands of viral mutants against antibodies of interest. This technique provides several advantages over traditional approaches:

  • Comprehensive coverage: DMS libraries can contain mutations spanning entire viral proteins, allowing for unbiased epitope discovery

  • Functional context: By testing mutations in the context of replication-competent virus, DMS approaches capture the functional consequences of mutations that might affect antibody binding

  • Validation capabilities: DMS libraries can confirm previously identified epitopes while also identifying new mutations that escape antibody neutralization

This approach has been successfully applied to map epitopes for well-characterized CHIKV monoclonal antibodies (mAbs) such as CHK-152 and CHK-265, while also providing new insights into the binding sites of mAbs with previously undefined specificities like CHK-11 .

What considerations are important when designing CHIKV mutant libraries for specific research applications?

When designing CHIKV mutant libraries for research applications, several key considerations should guide the experimental approach:

  • Target selection:

    • Structural proteins (like E2/E3) are ideal for studying entry, egress, and antibody interactions

    • Non-structural proteins (like nsP2 and nsP4) are suitable for investigating replication fidelity

    • 3'UTR is appropriate for exploring host adaptation mechanisms

  • Library generation method:

    • For comprehensive coverage, error-prone PCR or saturating mutagenesis approaches are effective

    • For specific hypothesis testing, site-directed mutagenesis may be more appropriate

  • Selection strategy:

    • Passage through relevant cell types to select functional variants

    • For host adaptation studies, alternating passage between mammalian and mosquito cells

    • For antibody escape studies, growth under increasing antibody pressure

  • Biosafety considerations:

    • For some applications, replication-incompetent systems may be used to avoid higher biosafety level requirements

    • When studying functions requiring complete viral replication, full-length infectious systems are necessary

The choice of experimental system should align with the specific research question while balancing comprehensive coverage with practical considerations of biosafety and resource requirements.

What emerging technologies could enhance our understanding of CHIKV genetic diversity and evolution?

Several emerging technologies show promise for advancing CHIKV mutant research:

  • Single-cell RNA sequencing of infected cells can provide insights into how host cell heterogeneity influences viral evolution and adaptation

  • Long-read sequencing technologies (e.g., Oxford Nanopore, PacBio) enable analysis of complete viral genomes from individual virus particles, providing better understanding of linkage between mutations

  • CRISPR-Cas systems adapted for RNA editing could allow precise engineering of CHIKV variants to test specific hypotheses about mutation effects

  • Advanced computational methods integrating structural biology with deep sequencing data could better predict how mutations impact viral fitness in different host environments

How might research on CHIKV mutants inform broader understanding of arbovirus adaptation and emergence?

Research on CHIKV mutants provides valuable insights that extend to other arboviruses:

  • The discovery that RNA recombination in the 3'UTR facilitates host adaptation suggests a potential common mechanism for arbovirus evolution during host switching

  • Understanding how viral population diversity correlates with disease severity may help predict which arbovirus lineages pose greater epidemic threats

  • Knowledge of selective pressures in mammalian versus mosquito hosts can inform surveillance efforts by identifying genetic signatures that might predict enhanced transmission or virulence

  • Methodologies developed for CHIKV mutant libraries, such as deep mutational scanning approaches, can be adapted to study other emerging arboviruses of public health concern

The principles and mechanisms elucidated through CHIKV mutant research thus provide a valuable framework for understanding the evolutionary dynamics and host adaptation strategies of the broader arbovirus family.

Product Science Overview

Introduction to Chikungunya Virus

Chikungunya virus (CHIKV) is an arthropod-borne virus belonging to the Alphavirus genus within the Togaviridae family. It is primarily transmitted to humans through the bites of infected mosquitoes, particularly Aedes aegypti and Aedes albopictus . The virus causes Chikungunya fever, characterized by sudden onset of fever, severe joint pain, muscle pain, headache, nausea, fatigue, and rash .

Structure and Function of E1 Glycoprotein

The CHIKV virion is enveloped and contains a single-stranded positive-sense RNA genome of approximately 11.8 kilobases. The viral envelope is derived from the host cell’s plasma membrane and includes two major glycoproteins, E1 and E2, along with a small 6K peptide . The E1 glycoprotein plays a crucial role in the virus’s ability to fuse with host cell membranes, facilitating viral entry and infection .

Mutation A226V in E1 Glycoprotein

During the 2005-2006 Chikungunya outbreaks, a significant mutation was identified in the E1 glycoprotein at amino acid position 226, where alanine was replaced by valine (A226V) . This mutation enhanced the virus’s ability to infect and replicate in Aedes albopictus mosquitoes, which are more widespread than Aedes aegypti . Consequently, the A226V mutation increased the epidemic potential of CHIKV by enabling more efficient transmission to human populations .

Recombinant E1 Glycoprotein

Recombinant CHIKV E1 glycoprotein, including the A226V mutant, is produced in insect cells for research purposes . The recombinant protein is a polypeptide chain containing amino acids 1-415, with the alanine at position 226 mutated to valine . This recombinant protein is used in various applications, including enzyme-linked immunosorbent assays (ELISA) and Western blotting, to study the virus’s properties and develop diagnostic tools .

Implications of the A226V Mutation

The A226V mutation has significant implications for CHIKV transmission and epidemiology. By increasing the virus’s ability to infect Aedes albopictus, the mutation has facilitated the spread of CHIKV to new geographic regions where this mosquito species is prevalent . This has led to larger and more widespread outbreaks, posing a greater public health challenge .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.